Compounds > 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
Page last updated: 2024-09-04

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Arthritis, Spinal

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione has been researched along with Arthritis, Spinal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carvalho, PD; Hmamouchi, I; Machado, PM; Marreiros, A; Vieira-Sousa, E1

Other Studies

1 other study(ies) available for 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Arthritis, Spinal

ArticleYear
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studies.
    Seminars in arthritis and rheumatism, 2022, Volume: 57

    Topics: Arthritis, Rheumatoid; Cross-Sectional Studies; Humans; Quality of Life; Spondylarthritis; Surveys and Questionnaires

2022